Marker for pancreatic cancer and intraductal papillary mucinous tumors

作者: Taniuchi Keisuke

DOI:

关键词:

摘要: The purpose of the present invention is to provide a marker that indicates pancreatic cancer and intraductal papillary mucinous tumors, with high sensitivity specificity. Furthermore, also diagnostic kit for which detects this marker, method evaluating metastatic using marker. This tumors characterized by including one or more proteins, selected from group consisting secretoglobin family-1D member 2, podocalyxin-like protein. an antibody proteins

参考文章(7)
Arnoldo Frigessi, Trine Tramm, Therese Sorlie, Hayat Mohammed, Simen Myhre, Anne-lise Borresen-Dale, Jens Overgaard, Jan Alsner, Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer ,(2013)
Jasmin Teresa Ney, Hui Zhou, Bence Sipos, Reinhard Büttner, Xin Chen, Günter Klöppel, Ines Gütgemann, Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts. Human Pathology. ,vol. 38, pp. 359- 364 ,(2007) , 10.1016/J.HUMPATH.2006.08.025
Kenoki Ohuchida, Kazuhiro Mizumoto, Takuya Egami, Hiroshi Yamaguchi, Kei Fujii, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi, Masao Tanaka, S100P Is an Early Developmental Marker of Pancreatic Carcinogenesis Clinical Cancer Research. ,vol. 12, pp. 5411- 5416 ,(2006) , 10.1158/1078-0432.CCR-06-0298
William Fitzhugh, Steve Ruben, Charles Birse, Vaibhav Narayan, Human podocalyxin alternative-spliced forms and uses thereof ,(2006)
Takadate Tatsuyuki, Onogawa Toru, Unno Tomoaki, Motoi Fuyuhiko, PANCREATIC CANCER BIOMARKER ,(2013)